A Prospective Observational Multicentric Clinical Trial to evaluate microscopic examination of various clinical samples by Artificial Intelligence based system - AI Microscopy

Sevamob Ventures Limited0 个研究点目标入组 1,200 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Inclusion criteria for superficial fungal infections: The patients visiting the skin outpatient department (OPD) in the hospital settings and suspected of fungal infections in skin or hair or nail by the dermatologist.
•2.Inclusion Criteria for community acquired lower Urinary Tract Infection (UTI): All the patients of symptomatic UTI Ã¢â?°Â¥18 years old from community with complaints of burning micturition and urgency.
•And not been admitted into the hospital for more than 48 hours in previous 1 month.
•3.Inclusion criteria for Blood smear examination: We will include 400 patients who are coming for routine Complete blood count (CBC) evaluation in haematology unit of Department of Pathology. Consent will be taken from the patient/ patient attendant when they will come for routine CBC in hematology lab.
•4.Inclusion criteria for pulmonary tuberculosis: Cases of suspected pulmonary tuberculosis whose sputum samples are submitted for AFB microscopy.

•1.Exclusion criteria for superficial fungal infections: Patients on antifungal therapy (oral as well as topical) for last 2Ã¢â?¬â??3 months. Patients with documented bacterial skin infections.
•2.Exclusion Criteria: Patients who had been on antibiotics 2 weeks or earlier prior to the study. Patients on phenazopyridine use in the prior 2 day, or with symptoms or signs of pyelonephritis, recent catheterization, or known anatomic or functional abnormalities of the urinary tract.
•3. All the patients of Aplastic anaemia, patients on chemotherapy and radiotherapy.
•4. Extra pulmonary tuberculosis, children/patients unable to expectorate sputum, patients unwilling to give consent.

发起方

Sevamob Ventures Limited